SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.190-0.8%Dec 24 12:58 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KMBJN. who wrote (12406)11/7/2019 12:21:51 AM
From: HardToFind1 Recommendation

Recommended By
Savant

   of 12873
 
Good to see the 10 big pharma companies in your list average over 75% gross margins, with COGS including manufacturing, sales, and executive/corporate overhead one would assume.
Just to clarify...

Gross margins do include:
  • manufacturing labor & materials
  • variable production costs
Gross margins do not include:
  • SG&A (sales, general & administrative expenses...sales, and executive/corporate overhead)
  • R&D or capital expendatures.
investopedia.com
Gross margins are basically revenues minus COGS.

investopedia.com
Cost of goods sold (COGS) refers to the direct costs of producing the goods sold by a company. This amount includes the cost of the materials and labor directly used to create the good. It excludes indirect expenses, such as distribution costs and sales force costs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News